Clinical Trials Logo

Clinical Trial Summary

Hidradenitis suppurativa (HS) is a chronic, recurrent and debilitating inflammatory skin disorder, characterized by painful inflamed nodules, abscesses and tunnels in the skin folds such as the axilla, inguinal region and gluteal area. The primary event in HS is occlusion of the hair follicle. HS is a notoriously difficult to treat disease, because treatment options are limited and evidence based treatments are scarce. Prevention of diseases is an important topic in medicine. However, current clinical trials in HS are focusing on anti-inflammatory drugs in patients with severe HS, whereas prevention and treatment of patients with more common mild HS is neglected. Laser hair removal therapy is a non-invasive procedure with minimal treatment discomfort for patients. Previous limited studies have suggested positive results in favor of laser hair removal therapy in HS. We therefore hypothesize that hair depilation using laser hair removal therapy may prevent the formation of new lesions and flares of the disease. The objective is to assess the efficacy of laser hair removal therapy in patients with mild to moderate HS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05762484
Study type Interventional
Source Erasmus Medical Center
Contact Hessel van der Zee, MD, PhD
Phone +31 10 704 0110
Email h.vanderzee@erasmusmc.nl
Status Not yet recruiting
Phase N/A
Start date April 2023
Completion date April 2026